Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2017

Medical Device Investing

Digirad (Nasdaq:DRAD) reported its financial results for the fourth quarter and twelve months ended December 31, 2017. As quoted in the press release: Net loss for the fourth quarter was $22.0 million, or $1.10 net loss per diluted share, compared to net income of $2.0 million, or $0.10 net income per diluted share in the …

Digirad (Nasdaq:DRAD) reported its financial results for the fourth quarter and twelve months ended December 31, 2017.

As quoted in the press release:

Net loss for the fourth quarter was $22.0 million, or $1.10 net loss per diluted share, compared to net income of $2.0 million, or $0.10 net income per diluted share in the same period in the prior year. Non-GAAP adjusted net loss for the fourth quarter was $2.7 million, or $0.14 adjusted net loss per diluted share, compared to adjusted net income of $3.0 million, or $0.15 adjusted net income per diluted share in the same period in the prior year. Non-GAAP adjusted EBITDA for the fourth quarter was $2.8 million, compared to $5.4 million in the same period in the prior year.

Click here to read the full press release.

financial results Medical Device Investing